Actio is advancing two lead rare disease programs – ABS-0871 and ABS-1230 – with first-in-class potential for the treatment of Charcot Marie Tooth disease, Type 2C (CMT2C) and a rare genetic ...

Actio is advancing two lead rare disease programs – ABS-0871 and ABS-1230 – with first-in-class potential for the treatment of Charcot-Marie-Tooth Disease, Type 2C (CMT2C) and KCNT1-related ...

SAN DIEGO, April 09, 2025--Actio Biosciences, a clinical-stage biotechnology company leveraging a novel platform approach to genetics and precision medicine to develop new therapeutics that target ...

Actio Biosciences Secures $66 Million Series B Financing to Advance Genetics-Driven Pipeline of Small Molecule Therapeutics for Rare and Common Diseases Provided by Business Wire Jun 18, 2025, 11: ...

Since she first emerged in 2013 with the superb Actio Reactio EP, Hauff has used her unadorned techniques to great effect, immediately grabbing the attention of various labels around the globe, as ...

Helena Hauff burst onto the scene in 2013 with Actio Reactio, released on Actress's label Werkdiscs. That album would change the life of Hamburg-based DJ and producer: since then her agent's phone ...

On March 30, she’ll return to Actress’s Werkdiscs imprint, the label that released her proper debut Actio Reactio back in 2013.

It's been a mere two years since Helena Hauff 's debut EP, Actio Reactio, came out on Actress's label Werkdisks, but she's already solidified herself as one of the most interesting producers ...

Helena Hauff releases her debut solo album via Werkdiscs / Ninja Tune. Titled 'Discreet Desires', it's the most in depth summation of the Golden Pudel resident DJ's improvised one-take machine-funk to ...